drugset / Trial / NCT02301780

Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia Prevention

NCT02301780 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Phase III two arm double-blinded randomised controlled trial to examine the effect of prophylactic low-dose aspirin from the first-trimester of pregnancy in women at increased risk for PET on the incidence and severity of the disease

Timeline

Start
2015-12
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 150 mg —

Indications